Jaguar Health announces 1-for-35 reverse stock split

Jaguar announced that it will effect a reverse stock split of its issued and outstanding voting common stock, at an exchange ratio of 1-for-35, on Thursday, April 30, 2026. The Company’s Common Stock will begin trading on a split-adjusted basis when the market opens on the Effective Date and will remain listed on The Nasdaq Capital Market under the symbol JAGX. The new CUSIP number for the Company’s Common Stock following the reverse stock split is 47010C862. The effectuation of the reverse stock split follows the approval of a proposal submitted to Jaguar stockholders at a Special Meeting of Stockholders.